2021 Q4 Form 10-Q Financial Statement

#000147793221008396 Filed on November 15, 2021

View on sec.gov

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	16169106	shares
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	USD
CY2021Q3	us-gaap	Assets Current AssetsCurrent	0	USD
CY2021Q2	us-gaap	Assets Current AssetsCurrent	0	USD
CY2021Q3	us-gaap	Assets Assets	0	USD
CY2021Q2	us-gaap	Assets Assets	0	USD
CY2021Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	29837	USD
CY2021Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1124	USD
CY2021Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	44344	USD
CY2021Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	45000	USD
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	74181	USD
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	46124	USD
CY2021Q3	us-gaap	Liabilities Liabilities	74181	USD
CY2021Q2	us-gaap	Liabilities Liabilities	46124	USD
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2021Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14669106	shares
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	16169	USD
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	14669	USD
CY2021Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2849266	USD
CY2021Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2805766	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2939616	USD
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2866559	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-74181	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-46124	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	0	USD
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	0	USD
CY2021Q3	us-gaap	Revenues Revenues	0	USD
CY2020Q3	us-gaap	Revenues Revenues	0	USD
CY2021Q3	us-gaap	Noninterest Expense Transfer Agent And Custodian Fees NoninterestExpenseTransferAgentAndCustodianFees	4133	USD
CY2020Q3	us-gaap	Noninterest Expense Transfer Agent And Custodian Fees NoninterestExpenseTransferAgentAndCustodianFees	3539	USD
CY2021Q3	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	USD
CY2020Q3	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	300000	USD
CY2021Q3	us-gaap	Professional Fees ProfessionalFees	53924	USD
CY2020Q3	us-gaap	Professional Fees ProfessionalFees	18000	USD
CY2021Q3	us-gaap	Management Fee Expense ManagementFeeExpense	15000	USD
CY2020Q3	us-gaap	Management Fee Expense ManagementFeeExpense	15000	USD
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	73057	USD
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	336539	USD
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-73057	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-336539	USD
CY2021Q3	us-gaap	Interest Expense InterestExpense	0	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	0	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-73057	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-336539	USD
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16169106	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15533236	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2906373	shares
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	-476843	USD
CY2020Q3	trxa	Shares Issued From To Be Issued Amount SharesIssuedFromToBeIssuedAmount	0	USD
CY2020Q3	trxa	Shares Issued From Private Sale Amount SharesIssuedFromPrivateSaleAmount	0	USD
CY2020Q3	trxa	Shares Issued For Services Amount SharesIssuedForServicesAmount	300000	USD
CY2020Q3	trxa	Shares Issued For Related Party Debt Conversion Amount SharesIssuedForRelatedPartyDebtConversionAmount	473616	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-336539	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	-39766	USD
CY2020Q4	trxa	Shares Issued For Related Party Debt Conversion Amount SharesIssuedForRelatedPartyDebtConversionAmount	80173	USD
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-41479	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-1072	USD
CY2021Q1	trxa	Shares Issued For Related Party Debt Conversion Amount SharesIssuedForRelatedPartyDebtConversionAmount	44873	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-43901	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-100	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-46024	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-46124	USD
CY2021Q3	trxa	Shares Issued For Related Party Debt Conversion Amount SharesIssuedForRelatedPartyDebtConversionAmount	45000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-336539	USD
CY2021Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.00
CY2020Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.12
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-73057	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-74181	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-73057	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-336539	USD
CY2021Q3	trxa	Shares To Be Issued For Services SharesToBeIssuedForServices	0	USD
CY2020Q3	trxa	Shares To Be Issued For Services SharesToBeIssuedForServices	300000	USD
CY2021Q3	trxa	Stock Issued StockIssued	45000	USD
CY2021Q3	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-656	USD
CY2020Q3	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	39075	USD
CY2021Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	28713	USD
CY2020Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2536	USD
CY2021Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	0	USD
CY2020Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	0	USD
CY2021Q3	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	USD
CY2020Q3	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	USD
CY2021Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	USD
CY2020Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	USD
CY2021Q3	us-gaap	Cash Period Increase Decrease CashPeriodIncreaseDecrease	0	USD
CY2020Q3	us-gaap	Cash Period Increase Decrease CashPeriodIncreaseDecrease	0	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	USD
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	USD
CY2021Q3	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2020Q3	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2021Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	USD
CY2020Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	USD
CY2021Q3	us-gaap	Stock Issued1 StockIssued1	45000	USD
CY2020Q3	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2021Q3	trxa	Shares To Be Issued For Services1 SharesToBeIssuedForServices1	0	USD
CY2020Q3	trxa	Shares To Be Issued For Services1 SharesToBeIssuedForServices1	300000	USD
CY2021Q3	us-gaap	Management Fee Expense ManagementFeeExpense	15000	USD
CY2021Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	44344	USD
CY2021Q3	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	598662	USD
CY2021Q3	trxa	Conversion Of Stock Shares ConversionOfStockShares	11380198	shares

Files In Submission

Name	View Source	Status
0001477932-21-008396-index-headers.html	Edgar Link	pending
0001477932-21-008396-index.html	Edgar Link	pending
0001477932-21-008396.txt	Edgar Link	pending
0001477932-21-008396-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
trxa-20210930.xsd	Edgar Link	pending
trxa-20210930_cal.xml	Edgar Link	unprocessable
trxa-20210930_def.xml	Edgar Link	unprocessable
trxa-20210930_lab.xml	Edgar Link	unprocessable
trxa-20210930_pre.xml	Edgar Link	unprocessable
trxa_10q.htm	Edgar Link	pending
trxa_10q_htm.xml	Edgar Link	completed
trxa_ex311.htm	Edgar Link	pending
trxa_ex321.htm	Edgar Link	pending